The University of Maryland Medical Center has announced that David Bennett, the 57-year old patient with terminal heart disease who made history as the first person to receive a genetically modified pig’s heart, passed away yeste


March 9, 2022 — Fujifilm Sonosite, Inc., a world leader in point-of-care ultrasound (POCUS) solutions today announced it has filed a patent infringement lawsuit against Butterfly Network in the United States District Court for the District of Delaware.

March 8, 2022 – Vitals Xchange is a cloud-based healthcare software that seamlessly connects with PointClickCare’s full-continuum platform which utilizes Emergency Medical Records (EMR) technology to streamline patient data transmission and analysis for various healthcare facilities.

March 8, 2022 – MemorialCare Heart & Vascular Institute (MHVI), through its advanced research program, is participating in a CSL Behring-sponsored multi-center, Phase III clinical trial – "ApoA-I Event reducinG in Ischemic Syndromes II (AEGIS-II) – which is studying the removal of cholesterol from the arteries to reduce the risk of a second heart attack or stroke in patients.

Mrach 8, 2022 – Diagnosing heart attacks after heart surgery remains difficult due to shortcomings of current diagnostic tools when applied to postoperative patients, including the electrocardiogram and blood tests to detect levels of cardiac troponins, according to an editorial in the New England Journal of Medicine (NEJM) written by two UT Southwestern faculty members.

March 7, 2022 — AdvaMed is saddened to share that a beloved member of the AdvaMed family, Wendy Siminski, Senior Vice President of Conferences and Events, has passed away after a brave battle with breast cancer. President and CEO Scott Whitaker released the following tribute:


Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of February. This data was drawn from dicardiology.com’s 149,000 viewers over the course of the month.


March 4, 2022 – NewAmsterdam Pharma (NAP), a clinical-stage company focused on the research and development of transformative therapies for cardiometabolic diseases, today announced dose administration for the first patient in its PREVAIL study, a global Phase 3 cardiovascular outcomes trial of the novel cholesteryl ester transfer protein (CETP) inhibitor obicetrapib.

March 3, 2022 – CIRCA Scientific, Inc. has announced that its S-CATH M Esophageal Temperature Probe is now cleared for sale in the United States. The new S-CATH M Probe can be visualized on 3D Cardiac Mapping Systems, which may help physicians reduce their dependence on fluoroscopy.

March 3, 2022 – Spontaneous coronary artery dissection (SCAD), a tear in an artery supplying blood to the heart, is a common cause of serious or fatal heart attacks that occur in women under age 50.

Subscribe Now